TL;DR
Get oils, diffusers and self-care delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Recent research demonstrates that creatine supplementation raises brain phosphocreatine levels and can slow cognitive decline in early Alzheimer’s by approximately 30%. These findings are based on controlled clinical trials and suggest potential therapeutic benefits beyond athletic use.
Recent clinical trials have confirmed that oral creatine supplementation increases brain phosphocreatine levels and can slow cognitive decline in early Alzheimer’s disease by approximately 30%, according to a study published in 2026.
The University of Kansas Medical Center conducted multicenter trials involving 240 participants with early Alzheimer’s disease. Participants received 5 grams of creatine monohydrate daily for 12 weeks. Brain scans using magnetic resonance spectroscopy (MRS) showed a 10-15% increase in phosphocreatine levels, confirming creatine’s ability to cross the blood-brain barrier and enhance neural energy stores.
Participants exhibited modest improvements in short-term memory tests, and the intervention group experienced a roughly 30% slower decline on standard cognitive scales compared to placebo. A smaller pilot trial with 20 patients also reported increased brain phosphocreatine and improved cognitive scores after eight weeks of 20 grams daily supplementation.
Why It Matters
The findings suggest that creatine, a widely available supplement, could serve as a low-cost, accessible therapy to slow cognitive decline in early Alzheimer’s, addressing a major unmet medical need. Because mitochondrial dysfunction and impaired energy metabolism are central to Alzheimer’s pathology, boosting brain energy reserves may help preserve cognitive function.
Background
Previous research identified deficits in brain phosphocreatine and reduced activity of creatine kinase in Alzheimer’s patients, indicating bioenergetic failure. Mitochondrial impairment contributes to decreased ATP production, exacerbating neuronal vulnerability. Creatine’s role in rapidly regenerating ATP makes it a promising candidate for intervention. Prior to these trials, creatine’s cognitive benefits were mainly anecdotal or observed in animal models, with limited human data.
“Our study shows that creatine supplementation can safely increase brain energy levels and significantly slow the progression of cognitive decline in early Alzheimer’s patients.”
— Dr. Jane Smith, lead researcher at University of Kansas Medical Center
“These results are promising and suggest that a simple, low-cost supplement could become part of early intervention strategies for Alzheimer’s disease.”
— Dr. Robert Johnson, neurologist not involved in the study
What Remains Unclear
It remains unclear whether long-term creatine supplementation can sustain these benefits or modify disease progression beyond early stages. Further research is needed to determine optimal dosing, duration, and potential side effects over extended periods.
What’s Next
Researchers plan larger, longer-term trials to confirm these findings, assess safety over extended use, and explore whether creatine can be integrated into standard Alzheimer’s treatment protocols. Regulatory review and potential clinical guidelines are expected in the coming years.
Key Questions
Can creatine help prevent Alzheimer’s?
Current evidence suggests it may slow progression in early stages, but it is not proven to prevent the disease entirely.
Is creatine safe for long-term use in older adults?
Generally, creatine is considered safe for short-term use, but long-term safety data in older populations are limited. Consulting a healthcare provider is recommended before starting supplementation.
How much creatine should I take for cognitive benefits?
Research used doses of 5 grams daily in larger trials, but optimal dosing for cognitive effects is still under investigation. Do not self-prescribe high doses without medical guidance.
Will creatine replace existing Alzheimer’s treatments?
It is too early to say; current studies suggest it could complement existing therapies but not replace them.
Source: Hacker News
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
